Free Trial
ASX:BIT

Biotron (BIT) Stock Price, News & Analysis

Biotron logo

About Biotron Stock (ASX:BIT)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.03 million shs
Average Volume
N/A
Market Capitalization
$9.93 million
P/E Ratio
N/A
Dividend Yield
5.08%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.

Remove Ads
Receive BIT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotron and its competitors with MarketBeat's FREE daily newsletter.

BIT Stock News Headlines

New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
See More Headlines

BIT Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotron investors own include TPG Co. Limited (TPM.AX) (TPM), Gemfields Group (GEM), Northern Star Resources (NST), Nokia Oyj (NOK), Mesoblast (MESO), MARA (MARA) and FYI Resources (FYI).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:BIT
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,440,000.00
Net Margins
-208.89%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.65 million
Price / Cash Flow
6.71
Book Value
A$0.00 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$9.93 million
Optionable
Not Optionable
Beta
-0.61
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (ASX:BIT) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners